Skip to content Skip to navigation



We conduct studies to develop safer, more efficient surgery in patients.

Evidence-based approaches for new surgical treatments and research to discover the molecular causes.


Sep 5 2019 | Posted In: 20/20 Blog, Press
Palo Alto, CA – The Stanford Ophthalmology Department highlighted its  clinical, surgical, and research achievements in its first annual report
Aug 13 2019 | Posted In: 20/20 Blog
Palo Alto, CA – An Ocular Melanoma Proteomics Symposium at Stanford University was hosted by Vinit Mahajan M.D., Ph.D., Vice Chair of Research in Ophthalmology, and Prithvi Mruthyun
Aug 9 2019 | Posted In: 20/20 Blog
Palo Alto, CA – As the eye ages, vision problems increase, making it harder to do everyday activities. When an older patient comes in with blurred or distorted central vision, one of the causes an ophthalmologist will check for is a macular hole.
Jul 19 2019 | Posted In: 20/20 Blog
Pacific Grove, CA – Every three years The Biology of Calpains in Health and Disease Conference brings together an international, multidisciplinary group of researchers who are examining the role calpains play in diseases like re
Jul 8 2019 | Posted In: 20/20 Blog
Palo Alto, CA – Vinit Mahajan M.D., Ph.D., Stanford vitreoretinal surgeon and Vice Chair of Research in the department of ophthalmology, gave an overview on molecular therapies at the 2019 Stanford’s Bay Area Ophthalmology Course